• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

灰阶超声未能确定的局灶性肝脏病变的特征:与对比增强超声、64 排 MDCT 和 MRI 与肝特异性对比剂的比较。

Characterisation of focal liver lesions undetermined at grey-scale US: contrast-enhanced US versus 64-row MDCT and MRI with liver-specific contrast agent.

机构信息

Dipartimento di Biotecnologie Mediche e Medicina Legale, Sezione di Diagnostica per Immagini, Policlinico Universitario, Via del Vespro 127, 90127 Palermo, Italy.

出版信息

Radiol Med. 2010 Aug;115(5):714-31. doi: 10.1007/s11547-010-0506-3. Epub 2010 Jan 15.

DOI:10.1007/s11547-010-0506-3
PMID:20082225
Abstract

PURPOSE

The aim of this study was to assess the role of contrast-enhanced ultrasonography (CEUS) in the characterisation of focal liver lesions in comparison with multidetector computed tomography (MDCT) and magnetic resonance imaging (MRI) with liver-specific contrast agent.

MATERIALS AND METHODS

One hundred and eighty-seven focal liver lesions, 91 malignant and 96 benign (mean size 3.2 cm) - proved by biopsy (n=12), histology (n=4), MDCT (n=108), MRI (n=44) MDCT/MRI (n=19) - in 159 patients were studied by CEUS. Two expert radiologists consensually evaluated the contrast-enhancement patterns at CEUS. For each lesion, they assessed: (a) nature (benign, malignant, not assessable), (b) specific diagnosis and (c) need for further radiological evaluation. Sensitivity, specificity, positive and negative predictive values and diagnostic accuracy of CEUS were calculated.

RESULTS

A total of 167/187 (89.3%) lesions were correctly assessed as benign or malignant at CEUS, whereas 14/187 (7.5%) lesions remained undetermined and 6/187 (3.2%) were incorrectly assessed. Sensitivity, specificity, positive and negative predictive values and diagnostic accuracy of CEUS were, respectively, 89%, 89.6%, 89%, 89.6% and 89.3%. The need for further radiological evaluation decreased to 46/187 (24.6%) lesions after CEUS (p<0.001).

CONCLUSIONS

In selected cases, CEUS can be considered an effective alternative to MDCT and MRI and reduce the need for further radiological workup.

摘要

目的

本研究旨在评估与多排螺旋 CT(MDCT)和磁共振成像(MRI)联合肝特异性对比剂相比,超声造影(CEUS)在局灶性肝脏病变特征描述中的作用。

材料与方法

对 159 例患者的 187 个局灶性肝脏病变(91 个恶性和 96 个良性病变,平均大小 3.2cm)进行了 CEUS 研究,这些病变通过活检(n=12)、组织学(n=4)、MDCT(n=108)、MRI(n=44)、MDCT/MRI(n=19)证实。两位专家放射科医生对 CEUS 增强模式进行了一致性评估。对于每个病变,他们评估了:(a)性质(良性、恶性、无法评估),(b)具体诊断,(c)是否需要进一步影像学评估。计算了 CEUS 的敏感性、特异性、阳性预测值、阴性预测值和诊断准确性。

结果

CEUS 正确评估了 167/187(89.3%)个病变为良性或恶性,而 14/187(7.5%)个病变仍未确定,6/187(3.2%)个病变被错误评估。CEUS 的敏感性、特异性、阳性预测值、阴性预测值和诊断准确性分别为 89%、89.6%、89%、89.6%和 89.3%。CEUS 后,进一步影像学检查的需求降至 46/187(24.6%)个病变(p<0.001)。

结论

在选择病例中,CEUS 可以被认为是 MDCT 和 MRI 的有效替代方法,并减少进一步影像学检查的需要。

相似文献

1
Characterisation of focal liver lesions undetermined at grey-scale US: contrast-enhanced US versus 64-row MDCT and MRI with liver-specific contrast agent.灰阶超声未能确定的局灶性肝脏病变的特征:与对比增强超声、64 排 MDCT 和 MRI 与肝特异性对比剂的比较。
Radiol Med. 2010 Aug;115(5):714-31. doi: 10.1007/s11547-010-0506-3. Epub 2010 Jan 15.
2
Focal liver lesions in cirrhosis: value of contrast-enhanced ultrasonography compared with Doppler ultrasound and alpha-fetoprotein levels.肝硬化中的局灶性肝病变:对比增强超声检查与多普勒超声及甲胎蛋白水平相比的价值
Radiol Med. 2008 Oct;113(7):978-91. doi: 10.1007/s11547-008-0316-z. Epub 2008 Sep 8.
3
[Focal liver lesions: clinical usefulness of contrast-enhanced ultrasound in the selection of surgical patients].[肝脏局灶性病变:超声造影在外科手术患者选择中的临床应用价值]
Chir Ital. 2009 May-Jun;61(3):295-307.
4
Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions - a prospective multicenter study of its usefulness in clinical practice.对比增强超声(CEUS)用于评估肝脏局灶性病变——一项关于其在临床实践中实用性的前瞻性多中心研究。
Ultraschall Med. 2014 Jun;35(3):259-66. doi: 10.1055/s-0033-1355728. Epub 2014 Feb 21.
5
Contrast-Enhanced Ultrasound for the Characterization of Malignant versus Benign Focal Liver Lesions in a Prospective Multicenter Experience - The SRUMB Study.对比增强超声在一项前瞻性多中心研究中用于鉴别良恶性局灶性肝病变的应用 - SRUMB 研究。
J Gastrointestin Liver Dis. 2019 Jun 1;28:191-196. doi: 10.15403/jgld-180.
6
Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.超声造影检查中不明原因的局灶性肝脏病变——从 DEGUM 多中心肝脏肿瘤特征性研究中吸取的经验教训。
Ultraschall Med. 2010 Dec;31(6):577-81. doi: 10.1055/s-0029-1245649. Epub 2010 Aug 25.
7
Contrast-enhanced ultrasound (CEUS) has excellent diagnostic accuracy in differentiating focal liver lesions: results from a Swiss tertiary gastroenterological centre.超声造影(CEUS)在鉴别局灶性肝脏病变方面具有出色的诊断准确性:来自瑞士一家三级胃肠病学中心的结果。
Swiss Med Wkly. 2019 Jun 30;149:w20087. doi: 10.4414/smw.2019.20087. eCollection 2019 Jun 17.
8
Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20  mm) and subcentimetric (≤ 10  mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial.CEUS 在鉴别诊断直径≤20mm 的小肝脏病变和≤10mm 的亚厘米肝脏病变与组织学的对比中的诊断准确性。DEGUM 多中心试验的结果。
Ultraschall Med. 2011 Dec;32(6):593-7. doi: 10.1055/s-0031-1271114. Epub 2011 Dec 9.
9
Contrast-enhanced ultrasonography in the evaluation of incidental focal liver lesions: A cost-effectiveness analysis.对比增强超声在评估肝脏偶发局灶性病变中的应用:一项成本效益分析。
World J Gastroenterol. 2016 Oct 14;22(38):8605-8614. doi: 10.3748/wjg.v22.i38.8605.
10
Can contrast-enhanced ultrasonography replace multidetector-computed tomography in the detection of liver metastases from colorectal cancer?在结直肠癌肝转移灶的检测中,超声造影能否取代多排螺旋计算机断层扫描?
Eur J Radiol. 2009 Feb;69(2):308-13. doi: 10.1016/j.ejrad.2007.10.023. Epub 2007 Dec 19.

引用本文的文献

1
Contrast-enhanced ultrasound for assessing blood flow modulation of hepatocellular carcinoma by hydralazine.超声造影评估肼苯哒嗪对肝细胞癌血流的调节作用
IEEE Int Ultrason Symp. 2022 Oct;2022. doi: 10.1109/ius54386.2022.9958467. Epub 2022 Dec 1.
2
Hydralazine-augmented contrast ultrasound imaging improves the detection of hepatocellular carcinoma.肼屈嗪增强对比超声成像提高肝细胞癌的检出率。
Med Phys. 2023 Mar;50(3):1728-1735. doi: 10.1002/mp.16232. Epub 2023 Jan 30.
3
Interobserver agreement for contrast-enhanced ultrasound of liver imaging reporting and data system: A systematic review and meta-analysis.

本文引用的文献

1
World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.《世界医学协会赫尔辛基宣言:涉及人类受试者的医学研究伦理原则》
JAMA. 2013 Nov 27;310(20):2191-4. doi: 10.1001/jama.2013.281053.
2
Focal liver lesions in cirrhosis: value of contrast-enhanced ultrasonography compared with Doppler ultrasound and alpha-fetoprotein levels.肝硬化中的局灶性肝病变:对比增强超声检查与多普勒超声及甲胎蛋白水平相比的价值
Radiol Med. 2008 Oct;113(7):978-91. doi: 10.1007/s11547-008-0316-z. Epub 2008 Sep 8.
3
Detection and characterization of focal hepatic lesions: comparative study of MDCT and gadobenate dimeglumine-enhanced MR imaging.
肝脏影像报告和数据系统的超声造影观察者间一致性:一项系统评价和Meta分析
World J Clin Cases. 2020 Nov 26;8(22):5589-5602. doi: 10.12998/wjcc.v8.i22.5589.
4
Radiological assessment of secondary biliary tree lesions: an update.继发性胆管树病变的影像学评估:最新进展
J Int Med Res. 2020 Jun;48(6):300060519850398. doi: 10.1177/0300060519850398.
5
Diagnostic value of contrast-enhanced ultrasound versus computed tomography for hepatocellular carcinoma: a retrospective, single-center evaluation of 234 patients.超声造影与 CT 对肝细胞癌的诊断价值:234 例回顾性单中心研究。
J Int Med Res. 2020 Jun;48(6):300060520930151. doi: 10.1177/0300060520930151.
6
CEUS LI-RADS: a pictorial review.CEUS LI-RADS:图文综述。
Insights Imaging. 2020 Feb 4;11(1):9. doi: 10.1186/s13244-019-0819-2.
7
Contrast-enhanced ultrasound of hepatocellular carcinoma: where do we stand?肝细胞癌的超声造影:我们目前的进展如何?
Ultrasonography. 2019 Jul;38(3):200-214. doi: 10.14366/usg.18060. Epub 2019 Feb 25.
8
Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition).结直肠癌肺转移多学科治疗专家共识(2019 年版)。
J Hematol Oncol. 2019 Feb 14;12(1):16. doi: 10.1186/s13045-019-0702-0.
9
Uncommon neoplasms of the biliary tract: radiological findings.胆道罕见肿瘤:影像学表现
Br J Radiol. 2017 Oct;90(1078):20160561. doi: 10.1259/bjr.20160561. Epub 2017 Jul 21.
10
Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases.磁共振成像、计算机断层扫描及对比增强超声在肝门周围肝转移瘤放射学多模态评估中的诊断准确性
PLoS One. 2017 Jun 20;12(6):e0179951. doi: 10.1371/journal.pone.0179951. eCollection 2017.
肝脏局灶性病变的检测与特征分析:多层螺旋CT与钆贝葡胺增强磁共振成像的对比研究
Clin Imaging. 2008 Jul-Aug;32(4):287-95. doi: 10.1016/j.clinimag.2007.11.004.
4
Economic assessment of contrast-enhanced ultrasonography for evaluation of focal liver lesions: a multicentre Italian experience.超声造影评估肝脏局灶性病变的经济学评价:意大利多中心经验
Eur Radiol. 2007 Dec;17 Suppl 6:F99-106. doi: 10.1007/s10406-007-0234-5.
5
Intrahepatic peripheral cholangiocarcinoma (IPCC): comparison between perfusion ultrasound and CT imaging.肝内周围型胆管癌(IPCC):超声灌注成像与CT成像的比较
Radiol Med. 2008 Feb;113(1):76-86. doi: 10.1007/s11547-008-0225-1. Epub 2008 Feb 25.
6
Focal liver lesions: contrast-enhanced ultrasound.肝脏局灶性病变:超声造影
Abdom Imaging. 2009 Mar-Apr;34(2):193-209. doi: 10.1007/s00261-008-9378-6.
7
Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography.局灶性结节性增生与肝腺瘤:低机械指数超声造影鉴别诊断
AJR Am J Roentgenol. 2008 Jan;190(1):58-66. doi: 10.2214/AJR.07.2493.
8
Contrast-enhanced ultrasonography in the characterization of benign focal liver lesions: activity-based cost analysis.对比增强超声在肝脏局灶性良性病变特征描述中的应用:基于活动的成本分析
Radiol Med. 2007 Sep;112(6):810-20. doi: 10.1007/s11547-007-0185-x. Epub 2007 Sep 20.
9
Hepatocellular cancer response to radiofrequency tumor ablation: contrast-enhanced ultrasound.肝细胞癌对射频肿瘤消融的反应:对比增强超声
Abdom Imaging. 2008 Sep-Oct;33(5):501-11. doi: 10.1007/s00261-007-9294-1.
10
Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation.超声造影下肝细胞癌的增强模式:与组织学分化的比较
Radiology. 2007 Sep;244(3):898-906. doi: 10.1148/radiol.2443061520.